| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,894 |
3,542 |
$275K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,000 |
1,933 |
$140K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
676 |
664 |
$83K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
476 |
442 |
$30K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
404 |
389 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
645 |
616 |
$25K |
| 99215 |
Prolong outpt/office vis |
137 |
127 |
$17K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
446 |
405 |
$15K |
| 99058 |
|
1,050 |
903 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
231 |
228 |
$6K |
| 87428 |
|
24 |
24 |
$2K |
| 81002 |
|
286 |
272 |
$697.78 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
14 |
$387.27 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$171.86 |
| 81025 |
|
13 |
13 |
$89.44 |